The magazine that focusses at identifying leading innovations and bring it to you for potential commercialization

1. #ResponsibleNutrition is an initiative to
bring awareness about the best practices
in nutrition business – development,
manufacturing and marketing of dietary
supplements, functional foods, and
nutritional ingredients for healthy
living.
#ResponsibleNutrition
Because nutrition is the
lifeline for people
Monthly
Bulletin on
Nutraceuticals
For any enquiries, please do reach us:
500 +
Business Empowered
10000
Network Members
6
Startups Impacted Exclusive Programs
83
Jobs Enabled by Program
> 200
USD 12 million
Nutraceuticals Commercializations
IMPACT CREATED SO FAR:
Nutrify Today is an idea-to-commercialization
company dedicated to empowering nutritional
businesses by way of expediting go to market at
about 50% of conventional time.
We are able to achieve innovation-to-market in the
shortest time frame because of the extensive
industry network we command. We currently
maintain a global database of over 10,000 members
to bring the best of innovation to our portfolio
design and commercialization.
More than
600 people have
already taken this pledge.
Now, it is your turn.
Take the Oath
hello@nutrifytoday.com
November
2021

2. Sheldon Baker
The trade show industry is a large marketing tool like no other. According to the research group Statista, the trade show industry
was valued at over US$15 billion in 2019. Then, the pandemic hit. Now, the late summer and fall seasons in the U.S. and
Europe, have brought with it a plethora of health and wellness trade shows. And am I delighted to see them.
August brought back SupplySide East in Secaucus, NJ. September featured Expo East in Philadelphia, PA. Vitafoods in
Geneva, Switzerland, appeared to be a huge success. And now the industry will take part in SupplySide West in Las Vegas, NV.
Add to the line-up MJBIZCON, also in Las Vegas, the largest CBD/Cannabis trade show of that category, and 2021 is going out
with a bang.
As the pandemic seems to have cooled off in many corners of the globe, numerous organizations have come back to the trade
show circuit. And 2022 shows have already started to attract a huge amount of interest. Of course, every organization will need
to make their own decision about when the right time to come back is and how to do so.
Some organizations have already announced plans to get back into in-person events. In cities like Las Vegas, where trade
shows are a key component of the economy, the signs of a resurgence have begun at a rapid pace, although not quite at
pre-pandemic levels.
Before we know it, Expo West, the largest natural products industry trade show featuring retail supplements, ingredients, and
food products, will take place March 2022 in Southern California. But before Expo West, Nutrify Today will celebrate its one-year
anniversary in February. Over the past year while we were all fighting off the pandemic crisis, Nutrify Today continued to bring
the industry together with news and information about various health and wellness issues affecting the business-to-business
community. Virtual regional and global forums, online newsletters and corporate introductions presented by Nutrify Today were
a Godsend.
February 2022 will bring a scheduled in-person C-Suite summit presented by Nutrify Today featuring a host of decision makers
from the nutraceutical and pharmaceutical arenas. Supply chain issues, technology, regulatory and marketing will be just some
of the topics and information that will be presented. Experts in their respective fields from India, East Asia, North America, and
other parts of the world will offer key insights into helping grow and sustain your business.
Be sure to watch for Nutrify Today C-Suite Summit details in the months ahead. And get your business casual clothing and
comfortable walking shoes ready, because that big marketing tool, the trade show, as well as educational summits, are getting
ready to bring you up close and personal to prospective buyers and business opportunities.
JUST WORDS…
FROM THE EDITOR
Nutraceutical Trade Shows and Summits are back
in Business
With healthy regards,
SHELDON BAKER
Editor-in-Chief
CEO, Baker Dillon Group

3. A LOOK AT AUSTRALIA’S TGA ADVERTISING
GUIDELINES
TGA APPROVED OR TGA REGISTERED
Many companies have and are considering introducing products in Australia. But there are
several government advertising guidelines that must be considered.
The inclusion of a therapeutic good in the Australian Register of Therapeutic Goods (ARTG)
is not an endorsement of that good by the Therapeutic Goods Administration (TGA).
Advertisers must not use terms such as 'TGA approved' or 'TGA registered' in therapeutic
goods advertising, including on labels or packaging. The use of a TGA logo or
Commonwealth Coat of Arms is also prohibited.
However, advertisers can include details of the product's ARTG number (and this number is
mandatory on medicine labels and packaging). For certain medicines, a 'TGA assessed
claim' can also be used in advertising1
.
References:
1. See sections 42DL(9) and 42DLB(6) of the Therapeutic Goods Act 1989 and section 16(2) of
the Therapeutic Goods Advertising Code (No.2).
Advertisers are prohibited from using a government logo or implying that any government
body (including a foreign government agency) endorses a therapeutic good. This includes
statements such as:
• 'TGA approved' or 'TGA endorsed'
• "U.S. Food & Drug Administration (FDA) approved"
• 'Government endorsed'

4. INCLUDING THE ARTG NUMBER
IN ADVERTISING
The ARTG contains information about
therapeutic goods that can be supplied in
Australia. Advertisers are encouraged to
provide the public with a product's 'AUST
L', 'AUST R' or ARTG number in
advertising as it assists consumers to
identify a product, and to look up the entry
in the ARTG if they wish to. Advertisers
can refer to the product's ARTG entry in a
compliant way by using terms such as:
However, advertisers should not make a broad statement that a therapeutic good is
listed, registered, or included in the ARTG unless it includes the ARTG number.
For more information, visit the TGA Advertising Hub or submit an advertising inquiry.
In particular, refer to:
• Advertising and endorsements
• Advertising to the public Section 16 of the Therapeutic Goods Advertising Code (No.2) 2018
RFA Regulatory Affairs, based in Sydney, Australia is a consulting firm that provides regulatory
advice for complementary medicines, foods, cosmetics, and medical devices. The RFA
website is www.robert-forbes.com.
TGA ASSESSED CLAIM IS PERMITTED FOR SOME MEDICINES
Assessed listed medicines and registered complementary medicines can be lawfully promoted
with the 'TGA assessed claim'. However, the use of this claim must be consistent with the
requirements published on the TGA website.
1. For devices: 'Product X is entered in the ARTG, (ARTG
number)'
2. For medicines and other therapeutic goods that are:
• Listed in the ARTG: 'Product X is listed in the ARTG, AUST L
(ARTG number)'
• Registered in the ARTG: 'Product X is registered in the ARTG,
AUST R (ARTG number)'

5. An interview with…
RAKESH AMIN
Partner
Amin Talati Wasserman,
LLP
By Sheldon Baker
Rakesh Amin serves as Partner with the law firm
of Amin Talati Wasserman (ATW), LLP. With
offices in several U.S. cities including Chicago,
Washington, D.C, and Los Angeles, Mr. Amin
and ATW represents companies in the food,
beverage, dietary supplement, cosmetic, drug,
medical device, and cleaning product
industries. He is known for his passion, sound
legal judgment, results, and relationships. The
firm’s clients include health and beauty brands,
suppliers, manufacturers, corporate law firms,
pharmaceutical, technology, retail and media
giants, private equity and venture firms,
accelerator groups, trade associations and
government-sponsored commerce groups.
Mr. Amin works on compliance issues involving
the Food, Drug & Cosmetic Act, The Federal
Trade Commission Act, The U.S. Department of
Agriculture, Proposition 65 and advertising
laws, patent and trademark protection and
infringement litigation, consumer false
advertising class actions, and commercial
litigation. Companies seeking to develop and
launch products turn to Mr. Amin and his team
for creative strategies to help label, advertise
and sell products, and protect, license, and
enforce brand names (trademarks) and
inventions (patents and trade secrets). He is a
board member of Naturally Chicago. The firm
serves as FDA regulatory counsel for The
Hemp Roundtable championing The Farm Bill
and path for CBD products. Amin Talati
Wasserman works with the Council for
Responsible Nutrition on FDA and advertising
regulatory issues. The firm is also general
counsel for The International Probiotics
Association, The Global Organization for EPA
and DHA Omega-3s (GOED-fish oil), The
American Botanical Council and NAXA for FDA,
Ad Law, trademarks, and IP.
Education wise, Mr. Amin possesses a L.L.M,
Health Law from DePaul University College of
Law, a J.D. from The John Marshall Law
School, a B.S. from Ferris State University
College of Pharmacy (Registered Pharmacist),
and he was an adjunct Food & Drug Law
professor at the DePaul University College of
Law.

6. Nutrify Today (NT): What are the primary areas of
practice Amin Talati Wasserman provides
nutraceutical companies?
Mr. Amin: Amin Talati Wasserman, LLP (ATW) is a
regulatory, intellectual property and litigation law
firm. We are a national boutique firm representing
a sophisticated, global client base in the food,
beverage, dietary supplement, cosmetic, drug
and medical device industries.
We have several primary areas of practice. The
list includes FDA Compliance, FTC, NAD and
State Advertising Compliance, Government
Investigations, Global Patent and Trade Secret
Protection and Enforcement, Global Trademark
and Copyright Protection and Enforcement, Trial
Practice, Litigation and Dispute
Resolution-Consumer Class Actions, Proposition
65 (California), Intellectual Property Litigation,
Supply Chain, Technology and Commercial
Litigation, and E-Commerce and Online
Marketplace Disputes.
We guide companies through the entire lifecycle
of their products, from development, clinical
trials, and regulatory approvals, to trademark,
patent, and trade secret protection, to import
issues, the creation of effective and compliant
advertising and labeling, defense against
challenges relating to intellectual property,
supply-chain, consumer class actions, and
business litigation, due diligence and assistance
to buyers and sellers in mergers, acquisitions,
and investments. Our goals are to consistently
produce first class results, ensure the highest
levels of client satisfaction, and develop
long-term relationships.
NT: ATW also represents pharmaceutical
manufacturers? What type of services?
Mr. Amin: Yes, we do. ATW represents brand, generic,
OTC monograph and homeopathic drug companies
with drug applications, approvals, labeling,
advertising, intellectual property protection, as well as
dispute resolution and litigation.
NT: Your firm represents global companies who enter
the U.S. Any challenges?
Mr. Amin: Yes. We represent many international
companies with the added challenges of having to
cross the border where FDA investigators are most
heavily staffed.
NT: What advice can you offer health and wellness
companies who want to enter the U.S. nutraceutical
marketplace?
Mr. Amin: We strongly suggest protecting your IP,
trademark protection and patent protection filing if
innovative and protectable, and buttoning up FDA and
FTC regulatory compliance as it applies to ingredients,
labeling and packaging prior to importation as an
ounce of prevention is worth 10 pounds of cure
nowadays in the U.S.
NT: What is the biggest challenge facing nutraceutical
senior management?
Mr. Amin: Preventing class action suits, Prop 65
(California) and similar shakedowns costing precious
time, focus and money.
NT: Does having close contact with the FDA help better
serve your clients?
Mr. Amin: Absolutely. We are friends and close
colleagues with FDA leaders and decision-makers. We
connect the government & compliance with our clients.
NT: Any new regulations on the horizon that may affect dietary supplement industry manufacturers?
Mr. Amin: There is nothing new regarding FDA regulatory. But what is newsworthy is new legislation coming from
California which is huge for the U.S. Hemp and CBD companies. Again, this relates in part to Prop 65.
The Hemp and CBD industry has been anxiously waiting for California to legalize the use of CBD in food,
supplements, and cosmetics, as well as pet products. After months of negotiation between the various
stakeholders, that day is finally arrived. California Governor Newson signed into law Assembly Bill 45, which is
effective immediately. Like other U.S. states that have legalized the sale of CBD products in recent years,
California’s law comes with its own testing, labeling, approved source, and registration requirements. For
example, the new law requires labels to include certain warning statements and a scannable barcode, website,

7. or QR Code linked to a certificate of analysis that provides specific testing information, among other label
requirements. These provisions only apply to products manufactured 90 days after the effective date.
AB 45 defines “THC” to include THCA, and any THC, including Delta-8 THC, Delta-9 THC, and Delta-10 THC. It
authorizes the Department of Public Health (DPH) to include or exclude comparable cannabinoids from the
definition of THC, based on their intoxicating effect, or lack thereof. In addition, DPH may impose maximum
serving sizes for hemp-derived cannabinoids, hemp extract, and products derived therefrom, active
cannabinoid concentration per serving size, the number of servings per container, and any other requirements it
deems necessary. In summary, the majority of the requirements under the new law are similar to existing
requirements, but some are unique to California, with possibly more on the way via future regulations, adding to
the ever-growing patchwork of state laws governing hemp and CBD products.
In other California news, the state’s Office of Environmental Health Hazard Assessment (OEHHA) issued a Notice
of Modification to its proposed regulations to require tailored warnings for Delta-9 THC (and cannabis smoke)
exposure warnings. The proposed regulations were originally the subject of a Notice of Proposed Rulemaking
issued on March 19, 2021, which was followed by a public hearing and comment period that ended in May. In
response to public comment, OEHHA has now proposed a one-year delayed effective date for the regulation to
allow businesses to transition to the new warnings (if they choose to use them). The agency has also proposed
an unlimited sell-through period for products manufactured prior to the effective date of the regulation and that
use the general “safe harbor” warning content. Comments regarding the notice are due by October 8.
In federal news, the FDA issued a Consumer Update in September on Delta-8 THC products. FDA outlines a
number of public health and safety risks associated with Delta-8 THC products, including the potential for
psychoactive and intoxicating effects, an uptick in adverse event reports to FDA and poison control centers, the
marketing of products in manner that is appealing to children, and concerns regarding contamination due to
methods of manufacturing and chemicals that may be used to produce Delta-8 THC products. FDA is actively
working with federal and state partners to further address the concerns related to these products and is
monitoring the market for product complaints, adverse events, and other emerging cannabis-derived products
of potential concern. On the same day, the Centers for Disease Control (CDC) issued its own advisory on Delta-8
THC, which discusses similar health and safety concerns. Of note, both FDA and CDC mention the potential for
consumers to confuse Delta-8 THC products with non-intoxicating hemp or CBD products, citing insufficient
labeling.
NT: Any legal and product trends you are seeing?
Mr. Amin: Increasing private enforcement with false advertising and Prop 65 challenges in California. Regarding
trends, plant-based proteins are on the rise.
NT: How do you evaluate success?
Mr. Amin: Doing my best to meet goals and initiatives one day at a time with a positive state of mind.
NT: What are you passionate about?
Mr. Amin: Family, friends, health, learning, fun for sure. On the business side, disruptive, innovative, functional,
and clean label products we get to work on.
NT: How can industry members get more information about ATW and your services?
Mr. Amin: They can email me at rakesh@amintalati.com and visit our website at www.AminTalati.com

8. info@gencorpacific.com
Clinically validated ingredients
Broad Regulatory Approvals
Available as Ready to market FDF's
Exclusive clinical evidence on female participants
Peer reviewed and published in high impact Journals
FOR LIBIDO, LEAN MUSCLE
MASS, MENOPAUSE
FOR CHRONIC PAIN
MANAGEMENT
FOR MENOPAUSE
MANAGEMENT
FOR WEIGHT
MANAGEMENT

9. Since Dr Stephen DeFelice coined the term “Nutraceutical” from “Nutrition” and
“Pharmaceutical” in 1989, it was used to describe medicinally or nutritionally functional foods.
Progressively, nutraceuticals, have also been called as medical / designer foods,
phytochemicals, functional foods and nutritional supplements, these include everyday products
as “bio” yogurts, fortified breakfast cereals, as well as vitamins, herbal remedies and recently
developed genetically modified foods and supplements. These nutraceuticals have received
considerable interest due to potential nutritional, safety and therapeutic effects.
The incidence of COVID-19 pandemic had bought in a paradigm shift in the nutraceutical
industry. The nutraceuticals, that were thought of as an elite platter of consumables have now
turned out to be the essential needs of most of the people enhancing immunity - a sensitive and
important feature resorted during this pandemic.
While the global nutraceuticals market as a whole is projected to grow at a CAGR of 7.5% during
the next five years (2020 - 2025), the global dietary supplements market size which was valued
at USD 140.3 billion in 2020 is expected to grow at a CAGR of 8.6%. Further, the sales of dietary
supplements that were $48 billion in 2019 grew to $52 billion in 2020, and are reported to reach
$58 billion this year. Among these increased sales, there are specific product categories with
particularly reported promising sales trends. This includes collagen peptides, immune
supplements, and stress supplements.
Nutraceuticals:
GLOBAL
NUTRACEUTICAL
GROWTH
For any business enquiries,
please write to us: hello@nutrifytoday.com

10. Nestlé, Abbott, KPN Innovations, Suntory Holdings, Korea Food Research Inst, Korea Institute of
Oriental Medicine, Chinese Academy of Science, Rag Foundation, Royal DSM NV and Aker
Biomarine covers 13% of the Nutraceuticals published/ granted during the past month.
Assignee Vs. Number of Patent Applications
Total Patents granted Vs. Patent Publications
Assignee Vs. Granted / Patent Publications
Number of patents analyzed & mapped: 721 records
Dominant Players (no. of records):
Nestle 43
Abbott 8
KPN Innovations 7
Suntory Holdings 7
Korea Food Research Inst. 6
Korea Institute of Oriental Medicine 6
Chinese Academy of Science 5
Rag Foundation 5
Royal DSM NV 5
Aker Biomarine 4
Independent Inventors 82
For any business enquiries,
please write to us: hello@nutrifytoday.com
Nutraceuticals:
IP INSIGHTS
A detailed patent study of Nutraceuticals for the past one month was carried out.
The search included a global coverage embracing all the granted as well as the
published patent literature. The study depicts the following:
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.)MDG)R0;,1.7)J)>;1.,1)>:E5+-;1+6,D()
)
;1.,1D)H0;,1.7)MDG)>;1.,1)>:E5+-;1+6,D)
))
0)6=)2;1.,1D);,;5F.7)a)8;22.7()TY?)0.-607D)
,1)>5;F.0D)X,6G)6=)0.-607D[()
]^)
A)
,6I;1+6,D) T)
)
)
QDD+H,..)MDG)R0;,1.7)J)>;1.,1)>:E5+-;1+6,D()
)
)
)
#61;5)>;1.,1D)H0;,1.7)MDG)>;1.,1)>:E5+-;1+6,D)
))
)
&:8E.0)6=)2;1.,1D);,;5F.7)a)8;22.7()TY?)0.-607D)
/68+,;,1)>5;F.0D)X,6G)6=)0.-607D[()
&.D15.) ]^)
QEE611) A)
b>&)%,,6I;1+6,D) T)
)
)
QDD+H,..)MDG)R0;,1.7)J)>;1.,1)>:E5+-;1+6,D()
)
)
)
#61;5)>;1.,1D)H0;,1.7)MDG)>;1.,1)>:E5+-;1+6,D)
))
)
&:8E.0)6=)2;1.,1D);,;5F.7)a)8;22.7()TY?)0.-607D)
/68+,;,1)>5;F.0D)X,6G)6=)0.-607D[()
&.D15.) ]^)
QEE611) A)
b>&)%,,6I;1+6,D) T)

11. Independent Inventors covers 11% of the Nutraceuticals Area.
Academia covers 20% of the Nutraceuticals Area for this month.
There are more of Patent Publications than the patents granted for the period of the last month,
showing the increased patent application filing activity in the nutraceutical space. However Patent
grants amount to 30%.
Nestlé (43) followed by Abbott (8), KPN Innovations (7), Suntory Holdings (7), Korea Food
Research Inst. (6), Korea Institute of Oriental Medicine (6) has 6 or more patent publications /
grants.
Nestlé (31) followed by Suntory Holdings (6), Abbott (5), Korea Institute of Oriental Medicine (5) and
Rag Foundation (5) are reported to have more patent publications in Nutraceutical space in the past
month.
The Patent Grants obtained for nutraceuticals in the past month are from Nestlé (12) followed by
Nestlé (9) followed by KPN Innovations (5), Abbott. (3), Korea Food Research Inst. (2), Chinese
Academy of Science (2), Royal DSM NV (2), Aker Biomarine (2), Suntory Holdings (1) and Korea
Institute of Oriental Medicine (1)
Nestlé has 12 granted patents in this month.
Technology Graph
Nutraceuticals:
Global
IP Insights
)
#.-3,656HF)R0;23)=60)13.)2;D1)6,.N86,13)%>);-1+I+1F)6,)13.)&:10;-.:1+-;5)*2;-.)
#3.)3.;I+.D1)-6,-.,10;1+6,)6=);01)5+.D)+,)/+.1;0F)*:225.8.,1D)X_?V[B)=6556C.7)EF)4:,-1+6,;5)4667D)
XY?V[B)4:,-1+6,;5)e.I.0;H.D)X?]V[B)!13.0D)X?V[)a)*6=1C;0.)X^V[)0.5;1.7);225+-;1+6,DG)
#3.),:10;-.:1+-;5D)13;1);0.):D.7)=60)E.;1+=+-;1+6,)2:026D.DB)60);D).DD.,1+;5)6+5D)=60)=0;H0;,-.DB)2;1.,1)
;225+-;1+6,D);E6:1)+,H0.7+.,1).W10;-1+6,DB)K+1D)a)7.I+-.D)16)20.2;0.)2.0D6,;5+.7)=667DB),6,N7+;0F)
=667)-6826D+1+6,DB)e+11.0,.DD)8;DK+,HB)D:H;0)=0..)-;,7F)8;,:=;-1:0+,H)8.1367B)60)13;1);DD+D1)+,)
=667)2;-K;H+,H);0.)H06:2.7):,7.0)613.0DG)
#0;7+1+6,;5)>3F16,:10+.,1D);0.)6ED.0I.7)16)3;I.)13.)3.;I+.D1)-6,-.,10;1+6,)+,);55)13.)-;1.H60+.D)6=)
&:10;-.:1+-;5DG))
/+.1;0F)*:225.8.,1D)X]^@[)=6556C.7)EF)4:,-1+6,;5)4667D)X?UU[B)4:,-1+6,;5)e.I.0;H.)X@A[);,7)
D6=1C;0.)XYY[)
#3.)-6,-.,10;1+6,)6=);01)+,):D.)6=)D6=1C;0.)+,)13.),:10;-.:1+-;5D)+D)0.2601.75F)+,-0.;D.7)13+D)86,13)
16)YY)=+5+,HD);D)-682;0.7)16)5;D1)86,13)C3+-3)C.0.)6,5F)?ZG))
Technology Graph for the past one-month IP activity on the Nutraceutical Space
The heaviest concentration of art lies in Dietary Supplements (61%), followed by Functional Foods
(21%), Functional Beverages (14%), Others (1%) & Software (3%) related applications.
The nutraceuticals that are used for beatification purposes, or as essential oils for fragrances, patent
applications about ingredient extractions, kits & devices to prepare personalized foods, non-diary
food compositions, Bitterness masking, sugar free candy manufacturing method, or that assist in
food packaging are grouped under others.
For any business enquiries,
please write to us: hello@nutrifytoday.com

12. Traditional Phytonutrients are observed to have the heaviest concentration in all the categories of
Nutraceuticals.
Dietary Supplements (439) followed by Functional Foods (155), Functional Beverage (98) and
software (22)
The concentration of art in use of software in the nutraceuticals is reportedly increased this month to
22 filings as compared to last month which were only 10.
Botanicals / Herbal (322) based Dietary Supplements report to be more lucrative followed by
Proteins (31), Omega Fatty Acids (20), Vitamins (17) and Special Carbohydrates (11) in the Dietary
Supplements. Alternate sweeteners (6) were notably reported this month.
Dairy / Dairy Alternatives (32) followed by Antioxidant based drinks (12) and non-carbonated drinks
(10) are found more lucrative amongst the Functional Beverages.
Prebiotics / Probiotics Fortified Foods (112) followed by Fortified flours / foods (33) are found more
lucrative amongst the Functional Foods.
Botanicals /Herbal (314) based Dietary Suppliments report to be more lucrative followed by Proteins
(16), Vitamins (16) and Omega Fatty Acids (18) in the Dietary Supplements.
Dairy / Dairy Alternatives (24) followed by Non-Carbonated Drinks (7) and fruit juices (6) are found
more lucrative amongst the Functional Beverages.
Prebiotics / Probiotics Fortified Foods (50) followed by Fortified flours / foods (11) and Dietary Fibres
(6) are found more lucrative amongst the Functional Foods.
Top Assignees Vs. Nutraceutical Category
Nutraceuticals:
Global
IP Insights
)
)
&.D15f)0.2601D)3.;IF)-6,-.,10;1+6,)+,)4:,-1+6,;5)e.I.0;H.)XYZ[)=6556C.7)EF)/+.1;0F)*:225.8.,1D)
X?_[);,7)4:,-1+6,;5)4667D)XT[)13+D)86,13G)
*:,160F)c657+,HD)$17G)*36CD)+1D)8;P60);-1+I+1F)+,)4:,-1+6,;5)e.I.0;H.D)X_[)C3.0.);D)S6F;5)/*d)&M)
0.2601D)+1D);-1+I+1F)+,)4:,-1+6,;5)4667D)XU[)6,5F)=60)13+D)86,13G)
QEE611)0.2601D)8;P60);-1+I+1F)+,)/+.1;0F)*:225.8.,1D)X][)=6556C.7)EF)4:,-1+6,;5)4667D)X^[);,7)
4:,-1+6,;5)e.I.0;H.)X?[)
b>&)%,,6I;1+6,D)$$L)0.2601D)+1D);-1+I+1F)6,5F)+,)13.)D6=1C;0.NE;D.7),:10;-.:1+-;5);225+-;1+6,DG)%1gD)
;-1+I+1+.D);0.)0.2601.7)16)13.):D.)6=)d;-3+,.)$.;0,+,H);,7)Q01+=+-+;5)%,1.55+H.,-.)+,)13.)&:10;-.:1+-;5)
D2;-.G)
)
)
&.D15f)0.2601D)3.;IF)-6,-.,10;1+6,)+,)4:,-1+6,;5)e.I.0;H.)XYZ[)=6556C.7)EF)/+.1;0F)*:225.8.,1D)
X?_[);,7)4:,-1+6,;5)4667D)XT[)13+D)86,13G)
*:,160F)c657+,HD)$17G)*36CD)+1D)8;P60);-1+I+1F)+,)4:,-1+6,;5)e.I.0;H.D)X_[)C3.0.);D)S6F;5)/*d)&M)
0.2601D)+1D);-1+I+1F)+,)4:,-1+6,;5)4667D)XU[)6,5F)=60)13+D)86,13G)
QEE611)0.2601D)8;P60);-1+I+1F)+,)/+.1;0F)*:225.8.,1D)X][)=6556C.7)EF)4:,-1+6,;5)4667D)X^[);,7)
4:,-1+6,;5)e.I.0;H.)X?[)
b>&)%,,6I;1+6,D)$$L)0.2601D)+1D);-1+I+1F)6,5F)+,)13.)D6=1C;0.NE;D.7),:10;-.:1+-;5);225+-;1+6,DG)%1gD)
;-1+I+1+.D);0.)0.2601.7)16)13.):D.)6=)d;-3+,.)$.;0,+,H);,7)Q01+=+-+;5)%,1.55+H.,-.)+,)13.)&:10;-.:1+-;5)
D2;-.G)
For any business enquiries,
please write to us: hello@nutrifytoday.com
Nestlé reports heavy concentration in Functional Beverage (20) followed by Dietary
Supplements (16) and Functional Foods (7) this month.
Suntory Holdings Ltd. Shows its major activity in Functional Beverages (6) where as Royal
DSM NV reports its activity in Functional Foods (5) only for this month.

13. For any business enquiries,
please write to us: hello@nutrifytoday.com
Nutraceuticals:
Literature
Survey
The Literature Survey:
The literature Survey for the past one month was done in the area of Nutraceutical and the
study depicts the following:
Total Publications in top journals considered for study: 30
Insights:
Majority of the publications were found to be Clinical Case Studies (17) followed by Reviews
(11) and Perspectives (2) for this month.
General Nutrition followed by Digestive Health, Dairy and non diary based products target
delivery substances had been of major interest in the Clinical case studies this month.
Reviews on nutraceutical in Digestive Health, General Nutrition & General Wellbeing were
more followed by the ones used for immunity, packaging, diabetes.
Plant based cheese analogs and digestibility of finger millets were few among the interesting
Reviews for this month.
Pinto bean based gels as carriers for curcumin delivery is reported as one of the target deli-
very study in this month publications.
Abbott reports major activity in Dietary Supplements (4) followed by Functional Foods (3)
and Functional Beverage (1)
KPN Innovations LLC reports its activity only in the software-based nutraceutical
applications. It’s activities are reported to the use of Machine Learning and Artificial
Intelligence in the Nutraceutical space.
)
d;P60+1F)6=)13.)2:E5+-;1+6,D)C.0.)=6:,7)16)E.)L5+,+-;5)L;D.)*1:7+.D)X?T[)=6556C.7)EF)S.I+.CD)X??[);,7)
>.0D2.-1+I.D)XY[)=60)13+D)86,13G)
R.,.0;5)&:10+1+6,)=6556C.7)EF)/+H.D1+I.)c.;513B)/;+0F);,7),6,)7+;0F)E;D.7)2067:-1D)1;0H.1)7.5+I.0F)
D:ED1;,-.D)3;7)E..,)6=)8;P60)+,1.0.D1)+,)13.)L5+,+-;5)-;D.)D1:7+.D)13+D)86,13G)
S.I+.CD)6,),:10;-.:1+-;5)+,)/+H.D1+I.)c.;513B)R.,.0;5)&:10+1+6,)a)R.,.0;5)O.55E.+,H)C.0.)860.)
=6556C.7)EF)13.)6,.D):D.7)=60)+88:,+1FB)2;-K;H+,HB)7+;E.1.DG)
>5;,1)E;D.7)-3..D.);,;56HD);,7)7+H.D1+E+5+1F)6=)=+,H.0)8+55.1D)C.0.)=.C);86,H)13.)+,1.0.D1+,H)
S.I+.CD)=60)13+D)86,13G)
>+,16)E.;,)E;D.7)H.5D);D)-;00+.0D)=60)-:0-:8+,)7.5+I.0F)+D)0.2601.7);D)6,.)6=)13.)1;0H.1)7.5+I.0F)D1:7F)
+,)13+D)86,13)2:E5+-;1+6,DG)
)

14. 7.2+-1D)13.)=6556C+,H()
#61;5)>:E5+-;1+6,D)+,)162)P6:0,;5D)-6,D+7.0.7)=60)D1:7F()^Z)
7.2+-1D)13.)=6556C+,H()
#61;5)>:E5+-;1+6,D)+,)162)P6:0,;5D)-6,D+7.0.7)=60)D1:7F()^Z)
For any business enquiries, please write to us:
hello@nutrifytoday.com
DISCLAIMER
This report is based upon individual expert’s view/judgment. Such analysis may vary from expert to expert. The information, analyses
presented herein do not constitute legal advice or opinion. Therefore, this report should be seen as an input for illustrative purposes. The
results are based on available data from public and private information sources. This report is prepared as a technical input to support
technical discussions. This report should be indicative and Nutrify Today or it’s subsidiaries are not responsible for any commercial or legal
action based on this report.
Patent No.
WO2021204995A1
CN113453564A
EP3884039A1
Owner
Purac Biochem B.V, ;
Charest, David John, ;
Catalin, Iancu, ;
Kumar, Saurabh, ;
Postmus, Jarne, ;
Roozen, Lambertus
Henricus Elisabeth
Novi Delta Coffee
Trading Industry Co.,
Ltd.
Valneva SE
Inventor(s)
Charest, David John, ; Catalin,
Iancu, ; Kumar, Saurabh, ;
Postmus, Jarne, ; Roozen,
Lambertus Henricus Elisabeth
R.M. Nabello,; J. Lola Daorta
Dos Pecinio
GUEHENNEUX, Fabienne, ;
LEON, Arnaud, ;
MADELINE, Brice, ;
MOREAU, Karine
Publication Date
October 14,
2021
September
28, 2021
September
29, 2021
Title
Fermented Onion Composition
"Method For Producing An Edible
Substance From Halophytic Plants,
Use Of And System For
Corresponding Edible Products"
Food Products Comprising Avian
Stem Cells
Title
"Pinto bean protein-based acid-induced
cold-set gels as carriers for curcumin
delivery: Fabrication and
characterization"
"The science of plant-based foods:
Approaches to create nutritious and
sustainable plant-based cheese analogs"
Publication Date
October 16,
2021
October 5, 2021
Author(s)
Neda Aliabbasi, ZahraEmam-Djomeh, GholamrezaAskari,
Maryam Salami
Lutz Grossmann, David Julian McClements
Nutraceuticals…
Interesting IP &
Events
Name of the Event
International Conference on Nutraceuticals and Supplements
ICNS
International Conference on Nutraceuticals, Nutrition and
Foods ICNNF
International Conference on Food Chemistry, Nutraceuticals,
Nutraceutical Ingredients and Supplements ICFCNNIS
International Conference on Nutraceuticals and Foods ICNF
International Conference on Nutraceuticals, Dietary
Supplements, Functional Foods and Nutraceutical
Ingredients ICNDSFNI
Location
Singapore
Singapore
Rome, Italy
Istanbul, Turkey
Dubai, United Arab Emirates
Date of the Event
May 03-04, 2022
May 03-04, 2022
May 03-04, 2022
May 06-07, 2022
May 09-10, 2022

15. NUTRIFY TODAY ACADEMY LAUNCHES AN ONLINE
CERTIFICATION PROGRAM ON INDUSTRY READY
BRIDGING COURSES IN NUTRACEUTICALS.
Online certification program on Product Development & Commercialization
CERTIFICATION PROGRAMS
Learn from global thought leaders and practitioners
Network with diverse peers from across industries
Accelerate your career by gaining relevant skills
Access best practices and innovative technologies
Conduct path breaking collaborative research
Learn from global thought leaders and practitioners
COURSE MODULE
Introduction to Product Lifecycle Management (PLM)
Innovation & its Management – The “Innovation Funnel”
Design Thinking & its Application to New Food Product
Development
Introduction to Formulation & Process Design
Introduction to Sensory Evaluation & Consumer Science
for Foods
Scale-up & Commercialisation
WHO SHOULD JOIN:
If you are F&D and R&D professional in nutraceuticals, pharmaceuticals and food tech
If you are a food technology graduate wanting to build a career in the nutraceuticals formulation category
If you are an organization with inhouse R&D, F&D
http://academy.nutrifytoday.com/
Hyderabad: 603, Saptagiri Towers,Sardar Patel Rd, Begumpet, Hyderabad, Telangana 500016
Bangalore: PG51, MGM, 81 Chikalsandra, Bangalore, India 560061
Register Today
Get In Touch +91 953 801 1662
academy@nutrifytoday.com
academy.nutrifytoday.com